AMGN - CIK 0000318154
AMGEN INC (AMGN) reported net income of $4.09B for fiscal year 2024, down 39.1% from $6.72B in fiscal 2023. The figure comes from the company's audited annual report as filed with the SEC.
| Quarter | Period end | net income |
|---|---|---|
| Q1 | 2024-03-31 | -$113.00M |
| Q2 | 2024-06-30 | $746.00M |
| Q3 | 2024-09-30 | $2.83B |
Calendar quarters as standardized by SEC XBRL frames; the company's fiscal calendar may offset from calendar quarters.
AMGEN INC (AMGN) reported net income of $4.09B for fiscal year 2024, down 39.1% from $6.72B in fiscal 2023. The figure comes from the company's audited annual report as filed with the SEC.
In the following fiscal year (2025), AMGEN INC reported net income of $7.71B, an increase from the $4.09B reported in fiscal 2024.
See the full AMGN net income history or the complete income statement.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.